Citations for
1ADNP, ADNP2
ADNP/ADNP2 expression in oligodendrocytes: implication for myelin-related neurodevelopment.
Malishkevich A, Leyk J, Goldbaum O, Richter-Landsberg C, Gozes I.
J Mol Neurosci 57(2):304-13. doi: 10.1007/s12031-015-0640-4. 2015
2ADNP, ADNP2
Autophagy has a key role in the pathophysiology of schizophrenia.
Merenlender-Wagner A, Malishkevich A, Shemer Z, Udawela M, Gibbons A, Scarr E, Dean B, Levine J, Agam G, Gozes I.
Mol Psychiatry 20(1):126-32. doi: 10.1038/mp.2013.174. Epub 2013 Dec 24. 2015
3ADNP, HVDAS
A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP.
Helsmoortel C, Vulto-van Silfhout AT, Coe BP, Vandeweyer G, Rooms L, van den Ende J, Schuurs-Hoeijmakers JH, Marcelis CL, Willemsen MH, Vissers LE, Yntema HG, Bakshi M, Wilson M, Witherspoon KT, Malmgren H, Nordgren A, Annerén G, Fichera M, Bosco P, Romano C, de Vries BB, Kleefstra T, Kooy RF, Eichler EE, Van der Aa N.
Nat Genet 46(4):380-4. doi: 10.1038/ng.2899. Epub 2014 Feb 16. 2014
4ADNP, ADNP2
Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: deregulation in schizophrenia.
Dresner E, Agam G, Gozes I.
Eur Neuropsychopharmacol 21(5):355-61. doi: 10.1016/j.euroneuro.2010.06.004. Epub 2010 Jul 3. 2011
5ADNP, ADNP2
Silencing of the ADNP-family member, ADNP2, results in changes in cellular viability under oxidative stress.
Kushnir M, Dresner E, Mandel S, Gozes I.
J Neurochem 105(2):537-45. doi: 10.1111/j.1471-4159.2007.05173.x. Epub 2007 Dec 19. 2008
6ADNP, ADNP2, VIP
Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo.
Giladi E, Hill JM, Dresner E, Stack CM, Gozes I.
J Mol Neurosci 33(3):278-83. Epub 2007 Oct 2. 2007
7ARFGEF2, ARPHM, TMSL6, ADNP, MOCS3, CZF1, ZFP64
Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex.
Sheen VL, Ganesh VS, Topcu M, Sebire G, Bodell A, Hill RS, Grant PE, Shugart YY, Imitola J, Khoury SJ, Guerrini R, Walsh CA.
Nat Genet 36(1):69-76. Epub 2003 Nov 30. 2004
8ADNP
Cloning and characterization of the human activity-dependent neuroprotective protein.
Zamostiano R, Pinhasov A, Gelber E, Steingart RA, Seroussi E, Giladi E, Bassan M, Wollman Y, Eyre HJ, Mulley JC, Brenneman DE, Gozes I.
J Biol Chem 276(1):708-14. 2001
9ADNP
Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide.
Bassan M, Zamostiano R, Davidson A, Pinhasov A, Giladi E, Perl O, Bassan H, Blat C, Gibney G, Glazner G, Brenneman DE, Gozes I.
J Neurochem 72(3):1283-93. 1999
10ADNP, AKAP9, ANGEL1, ARHGAP32, ATP10B, ATP1A2, BAG5, BAIAP3, CAMKK2, CLCC1, CLSTN3, DDHD2, DDN, DDX46, DDX46, DGKB, DIP, DOCK4, DST, EIF5B, EPM2AIP1, FAM131B, FAM153A, FARP2, FCHSD2, GPR116, HDAC9, IPO13, KBTBD11, KIAA0748, KIAA0753, KIAA0754, KIAA0802, KLHL18, LARP1, LPHN2, LPHN3, LRIG2, MAST2, MTUS2, MYO10, MYO1D, NFASC, NRXN3, NUP155, OSBPL2, PCNX, PHF14, PPP1R13B, RAD54L2, RBM12, RHOBTB1, RHOBTB2, RIMS2, SACS, SASH1, SEC24A, SEC24B, SEC24C, SEC24D, SENP6, SLC4A8, SNRNP200, SNX13, SORBS2, SPATA2, SPON1, SUPT7L, SV2A, SV2B, SYNE1, TBKBP1, TCAF1, TMCC1, TMEM63A, TOMM70A, TSPYL4, UBXN7, ULK1, USP34, VPRBP, VPS39, VPS8, WSCD2, XPO7, ZBED1, ZBED1Y, ZNF294, ZNF423, ZNF432
Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.
Nagase T, Ishikawa K, Suyama M, Kikuno R, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O.
DNA Res 5(5):277-86. 1998